|  Wall
Street Advisor provides fundamental investment
research on public companies. Our independent
research is used by money managers, stockbrokers,
high net worth individuals, financial planners,
investment clubs, investor relations firms
and individual investors who demand high-quality
investment research information that is
free from conflict of interest. We do not
offer investment banking or brokerage services.
A majority of our analysts have earned the
Chartered Financial Analyst (CFA) certification
of the Association for Investment Management
and Research (AIMR). And to ensure that
our analyses are "the best and the
brightest" available, our analysts
specialize in particular fields, including
health care, technology, communications,
software, manufacturing, energy, information
technology and financial institutions. More...
|
|
|
| 
Neil
Prior
Chief Executive Officer
Atlantic Tele-Network
ANK - AMEX |
| |
Neil
Prior discusses his company’s valuation
and the market for international phone services.
More... |
|
|
|  Former
SEC Chairman Arthur Levitt gave his endorsement
of the independent research model in an
interview with the Bloomberg news service
published May 8, 2002. Discussing the need
to reduce analyst conflicts of interests
in the wake of news surrounding Merrill
Lynch, Levitt said, “I think what we’re
looking for in this new world, … is the
development of independent research boutiques
that sell their research.” More...
|
|
|
| 
| Medical
Devices Council
March 26, 2004
Yale Club, NYC 5:30 – 7:00
Generex Biotech
World Heart Corporation
Biolase Technology
Biophan Technology
Investor
Council Schedule |
|
|
|
 |
| 
 DOR BioPharma, Inc.
DORB OTCBB
DOR BioPharma is a biopharmaceutical company addressing the life-threatening side effects of cancer and cancer treatments, serious gastrointestinal diseases and disorders, and biodefense vaccines. Its lead product orBec® is a potent, locally acting corticosteroid being developed for the treatment of gastrointestinal graft-versus-host disease (GI GVHD). GI GVHD is a common serious complication of bone marrow and stem cell transplantation for cancer. DOR’s vaccine program is focused on two potent and weaponizable biological toxins, ricin and botulinum. More...
|
|
 Nutrition
21, Inc.
NXXI NasdaqSC
Nutrition
21, Inc. is a nutritional biosciences company
dedicated to the research, development and
commercialization of innovative chromium-based
products for use in improving the structure
and function of the body, and in the prevention
and treatment of metabolic diseases such
as diabetes, insulin resistance, obesity,
depression and cardiovascular disease. The
function of insulin, the body’s master
metabolic hormone, is in part dependent
on chromium that must be supplied through
diet or supplementation. The Company markets
Chromax chromium picolinate, which is the
most studied form of the essential mineral
chromium. Nutrition 21 holds 36 patents
for nutrition products, 22 for chromium
compounds and their uses. The Company currently
licenses chromium picolinate to vitamin
and supplement manufacturers and marketers
for use in human and animal nutritional
products. More...
|
|
| 
Incentra
Solutions Inc.
ICNS – OTC
Incentra
Solutions is a supplier of complete computer
data storage solutions to broadcasters,
enterprises and managed service providers
worldwide. The Company markets its complete
storage solutions to broadcasters under
the trade name Front Porch Digital (FPD)
and to service providers and enterprise
clients under the trade name Managed Storage
International (MSI). Front Porch provides
software and professional services for digital
archive management to broadcasters and media
companies worldwide. MSI delivers comprehensive
storage and IT services to enterprise customers.
More...
|
|
 Delcath
Systems, Inc.
DCTH - NasdaqSC
Delcath
Systems, Inc. has developed a patented system
to isolate the liver from the general circulatory
system and to administer chemotherapy and
other therapeutic agents directly to the
liver. The Delcath system delivers chemotherapy
to the liver and cleanses the blood of the
chemotherapy before its return from the
liver. The rest of the body is therefore
protected from the harmful side effects
of chemotherapy. The entire Delcath procedure
is minimally invasive and takes about 2.5
hours, with patients under local anesthesia.
More…
|
|
|
Stellar
International Inc. develops and markets:
1) NeoVisc a viscosupplement, for the treatment
of osteoarthritis and 2) Uracyst for the
diagnosis and treatment of interstitial
cystitis (an inflammatory disease of the
urinary bladder wall). The Company also
in-licenses two additional products for
the Canadian market: Skelite, a synthetic
bone grafting product; and BladderChek,
a diagnostic test for bladder cancer. Stellar
sells all of four products directly in Canada
and out-licenses products for all other
markets. Stellar’s strategic partner
in the U.S., SJ Pharmaceuticals, will pay
for and conduct the Phase III trials which
are necessary in the U.S.
October
7, 2004 Report
November
17, 2004 Update
|
|
|
Generex
Biotechnology Corporation is engaged in
the research and development of drug delivery
technologies. The Company's unique oral
delivery technology platform has been designed
for the pain-free, accurate and safe delivery
of large molecule drugs such as insulin.
Unlike small molecule drugs, which generally
can be administered by various methods,
large molecule drugs historically have been
administered primarily by injection. The
Company's proprietary RapidMist™ device
administers large molecule drugs directly
into the mouth as a metered dose spray for
rapid absorption by the mucous membranes
of the oral cavity (rather than the lungs).
More…
|
|
|
JMAR
Technologies, founded in 1987, is a semiconductor
equipment company. The Company has two segments:
1) front-end semiconductor equipment and
services, and 2) precision equipment. Front-end
Semiconductor Equipment and
Services conceive and create leading-edge
microelectronics manufacturing systems based
on patented X-ray and other advanced light
sources for higher-performance semiconductor
manufacturing and inspection. JMAR Precision
Systems manufactures state-of-the art precision
inspection, motion control and light-based
manufacturing and metrology systems for
the microelectronics industry. More…
|
|
|
BLTI
is a medical technology company that designs,
develops, manufactures and markets advanced
dental, cosmetic and surgical products.
More…
|
|
|
DSCO
a development stage pharmaceutical company
that focuses on developing compounds to
treat respiratory diseases that affect the
ability of the lungs to absorb oxygen.
More… |
|
|
Biophan
Technologies, Inc. provides solutions for
making biomedical devices safe for use with
magnetic resonance imaging (MRI) devices
and to reduce the interference these devices
cause to the quality of MRI images. The
solutions include coatings, filters, and
photonics and can be applied to a wide range
of implanted biomedical devices, as well
as those used in surgical and diagnostic
procedures (interventional medicine). The
list of implantable devices that can benefit
from Biophan’s technologies includes
pacemakers, defibrillators, neurostimulators,
stents, guide wires, aneurysm clips, biopsy
needles, and many others. More…
|
|
|
|
